Friday, October 10, 2025

6:30 AM – 7:30 AM: Symposium

Charlotte Convention Center
501 S College St, Charlotte, NC
Meeting Room: Room 217

PROGRAM FEATURES

NEED

PRESENTING FACULTY

	Linda Laux, MD Epilepsy Center, Department of Pediatrics Ann & Robert H Lurie Children’s Hospital Chicago, Illinois
	Joseph Sullivan, MD Department of Pediatrics, University of California San Francisco, California

PROGRAM OVERVIEW

This Whiteboard Satellite Symposium featuring two leading experts in pediatric epilepsy and genetic neurodevelopmental disorders will be available live and virtually during the 54^th Child Neurology Society Annual Meeting. The session will offer an interactive and visually engaging learning experience through high-definition slides, immersive whiteboard animation, and real-world case presentations. The overall program will provide a comprehensive overview of the latest clinical guidelines and explore best practices for providing individualized treatment for patients with Dravet Syndrome. Additionally, our experts will highlight the latest advances in genetic based therapies— ranging from clinical trial data, potential biomarkers, and the future role of these therapies in routine clinical practice.

LEARNING OBJECTIVES:

• Assess the pathophysiology, etiology, and clinical manifestations of Dravet syndrome (DS) to categorize accurately
• Implement strategies that implement current standards of care for DS to optimize disease management and improve the quality of life for patients and their caregivers
• Adopt evidence-based, expert recommendations regarding genetic testing and theVineland-3 assessment to effectively diagnose and evaluate patients with DS
• Summarize the future role of DMTs within the DS treatment landscape, including efficacy and safety data on emerging genetic-based therapies

TARGET AUDIENCE

This activity is designed to meet the educational needs of pediatric neurologists, pediatric epileptologists, and pediatric nurse practitioners and physician assistants involved in diagnosing and caring for patients with Dravet syndrome

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Medical Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT 

Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSES (ANCC) CREDIT DESIGNATION 

Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hours.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group at [email protected]